Clinical Trial Update: Selective Retina Therapy (SRT) in Patients With Idiopathic Central Serous Retinopathy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Selective Retina Therapy for idiopathic central serous chorioretinopathy has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Drugs mentioned

• Selective Retina Therapy

Snippet

Sponsor: University of Kiel | Conditions: Central Serous Chorioretinopathy, Selective Retina Therapy | Phase 2 | Status: COMPLETED